Dudek K, Paton S, Binder L, Collignon A, Dion-Albert L, Cadoret A
Nat Neurosci. 2025; .
PMID: 40016352
DOI: 10.1038/s41593-025-01891-9.
Navarri X, Robertson D, Charfi I, Wunnemann F, Samia Fernandes do Nascimento A, Trottier G
J Neurosci. 2024; 44(41).
PMID: 39214708
PMC: 11466068.
DOI: 10.1523/JNEUROSCI.2256-23.2024.
Morales-Soto W, Thomasi B, Gulbransen B
Glia. 2024; 72(11):2095-2114.
PMID: 39132860
PMC: 11563875.
DOI: 10.1002/glia.24599.
Singh S, Ellioff K, Bruchas M, Land B, Stella N
J Pharmacol Exp Ther. 2024; 391(2):162-173.
PMID: 39060165
PMC: 11493443.
DOI: 10.1124/jpet.124.002119.
Chowdhury K, Holden M, Wiley M, Suppiramaniam V, Reed M
Cells. 2024; 13(13.
PMID: 38994982
PMC: 11240741.
DOI: 10.3390/cells13131130.
Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years.
Haller J
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931356
PMC: 11206863.
DOI: 10.3390/ph17060689.
Transcriptional profiling of retinal astrocytes identifies a specific marker and points to functional specialization.
Cullen P, Gammerdinger W, Ho Sui S, Mazumder A, Sun D
Glia. 2024; 72(9):1604-1628.
PMID: 38785355
PMC: 11262981.
DOI: 10.1002/glia.24571.
Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment.
Stanciu G, Ababei D, Solcan C, Uritu C, Craciun V, Pricope C
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675490
PMC: 11053678.
DOI: 10.3390/ph17040530.
Cannabinoid type-1 receptor signaling in dopaminergic Engrailed-1 expressing neurons modulates motivation and depressive-like behavior.
Baddenhausen S, Lutz B, Hofmann C
Front Mol Neurosci. 2024; 17:1379889.
PMID: 38660383
PMC: 11042029.
DOI: 10.3389/fnmol.2024.1379889.
Acute and Chronic Neural and Glial Response to Mild Traumatic Brain Injury in the Hippocampus.
Dougan C, Roberts B, Crosby A, Karatsoreos I, Peyton S
bioRxiv. 2024; .
PMID: 38617329
PMC: 11014627.
DOI: 10.1101/2024.04.01.587620.
Sleep, Glial Function, and the Endocannabinoid System: Implications for Neuroinflammation and Sleep Disorders.
Camberos-Barraza J, Camacho-Zamora A, Batiz-Beltran J, Osuna-Ramos J, Rabago-Monzon A, Valdez-Flores M
Int J Mol Sci. 2024; 25(6).
PMID: 38542134
PMC: 10970053.
DOI: 10.3390/ijms25063160.
Astrocytic Regulation of Endocannabinoid-Dependent Synaptic Plasticity in the Dorsolateral Striatum.
Adermark L, Stomberg R, Soderpalm B, Ericson M
Int J Mol Sci. 2024; 25(1).
PMID: 38203752
PMC: 10779090.
DOI: 10.3390/ijms25010581.
Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia.
Canseco-Alba A, Tabata K, Momoki Y, Tabassum T, Horiuchi Y, Arinami T
Prog Neuropsychopharmacol Biol Psychiatry. 2023; 130:110924.
PMID: 38135096
PMC: 10872318.
DOI: 10.1016/j.pnpbp.2023.110924.
Anxiety Modulation by Cannabinoids-The Role of Stress Responses and Coping.
Haller J
Int J Mol Sci. 2023; 24(21).
PMID: 37958761
PMC: 10650718.
DOI: 10.3390/ijms242115777.
β-Caryophyllene Inhibits Oxaliplatin-Induced Peripheral Neuropathy in Mice: Role of Cannabinoid Type 2 Receptors, Oxidative Stress and Neuroinflammation.
Agnes J, Dos Santos B, das Neves R, Luciano V, Benvenutti L, Goldoni F
Antioxidants (Basel). 2023; 12(10).
PMID: 37891972
PMC: 10604080.
DOI: 10.3390/antiox12101893.
Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges.
Wardill H, Wooley L, Bellas O, Cao K, Cross C, van Dyk M
Br J Cancer. 2023; 130(1):19-30.
PMID: 37884682
PMC: 10781684.
DOI: 10.1038/s41416-023-02466-w.
GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice.
Kulbe J, Le A, Mante M, Florio J, Laird A, Swinton M
J Neurovirol. 2023; 29(5):564-576.
PMID: 37801175
PMC: 10645617.
DOI: 10.1007/s13365-023-01155-x.
Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer's Disease: Implications for Controlling Astroglial Activity.
Pacheco-Sanchez B, Tovar R, Ben Rabaa M, Sanchez-Salido L, Vargas A, Suarez J
Int J Mol Sci. 2023; 24(16).
PMID: 37628778
PMC: 10454447.
DOI: 10.3390/ijms241612598.
Astrocytes as a target for therapeutic strategies in epilepsy: current insights.
Carcak N, Onat F, Sitnikova E
Front Mol Neurosci. 2023; 16:1183775.
PMID: 37583518
PMC: 10423940.
DOI: 10.3389/fnmol.2023.1183775.
Opposing retrograde and astrocyte-dependent endocannabinoid signaling mechanisms regulate lateral habenula synaptic transmission.
Winters N, Kondev V, Loomba N, Delpire E, Grueter B, Patel S
Cell Rep. 2023; 42(3):112159.
PMID: 36842084
PMC: 10846612.
DOI: 10.1016/j.celrep.2023.112159.